Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures
Author:
Publisher
Elsevier BV
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference11 articles.
1. Pharmacotherapy of epilepsy – current problems and controversies;Schmidt;Fortschr Neurol Psychiatr,1983
2. Longitudinal cohort studies of the prognosis of epilepsy: contributions of the National General Practice Study of Epilepsy and other studies;Shorvon;Brain,2013
3. Definition of drug resistant epilepsy. Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies;Kwan;Epilepsia,2010
4. Revised terminology and concepts for organization of seizures and epilepsies. Report of the ILAE Commission on Classification and Terminology, 2005–2009;Berg;Epilepsia,2010
5. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures;Lerche;Seizure,2015
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study;Journal of the Neurological Sciences;2024-08
2. Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study;Epilepsy Research;2024-05
3. Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study;Neurology and Therapy;2024-04-28
4. PERPRISE: A prospective non‐interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic‐clonic seizures: First interim analysis;Epilepsia Open;2023-11-28
5. Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study;Epilepsy & Behavior;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3